tm logo
B-BRIDGE
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 20 Mar 2015

Last Applicant/ Owned by

320 Logue Avenue

Mountain View

CA

94043

Serial Number

76664863 filed on 21st Aug 2006

Registration Number

3486764 registered on 19th Aug 2008

in the Principal Register

Correspondent Address

Maryam Imam

LAW OFFICES OF IMAM

Suite 1010

111 N. Market Street

San Jose CA 95113

Filing Basis

1. use application currently

Disclaimer

NO DATA

B-BRIDGE

Biosciences research products, namely, biochemical mechanisms used for research in the nature of transfection products, namely, quickstep transfection kit comprised of transfection reagents, for research purposes; Polymerase Chain Reaction (PCR) products, enzymes and reagents, namely, Taq deoxyribonucleic acid (DNA) Polymerase, Hot Start DNA Polymerase, deoxynucleotide triphosphate (dNTP) solutionRead More

Classification Information


Class [001]
Chemical Products


Biosciences research products, namely, biochemical mechanisms used for research in the nature of transfection products, namely, quickstep transfection kit comprised of transfection reagents, for research purposes; Polymerase Chain Reaction (PCR) products, enzymes and reagents, namely, Taq deoxyribonucleic acid (DNA) Polymerase, Hot Start DNA Polymerase, deoxynucleotide triphosphate (dNTP) solutions, namely, sets of all four dNTPs 2'-Deoxyadenosine 5'-Triphosphate (dATP), 2'-Deoxycytidine 5'-Triphosphate (dCTP), 2'-Deoxyguanosine 5'-Triphosphate (dGTP), and 2'-Deoxythymidine 5'-Triphosphate (dTTP)), and Real Time PCR Kits comprised of chemicals, namely, DNA polymerase, Globin mixture containing glycerol, potassium chloride (KCl), dATP, dCTP, dGTP, dTTP and primers, magnesium chloride (MgCl2), reagents, and blood for research purposes; nucleic acid purification products, namely, plasmid DNA isolation kits comprised of chemicals, namely, transfection reagents for research purposes, ribonucleic acid (RNA) purification kits comprised of chemicals, namely, transfection reagents for research purposes, and high throughput purification kits comprised of chemicals, namely, buffers and buffers for lysis, binding, wash and elute, and mannitol-adenine-phosphate (MAP) solution containing mannitol, adenine and crystalline sodium dihydrogen phosphate for research purposes; apoptosis detection kits comprised of reagents for research purposes and chemicals consisting of buffers, fixatives, and biochemical stains; diabetes and obesity research products, namely, chemicals in the nature of human and mouse/rat adiponectin, resistin, leptin, and leptin-receptor enzyme-linked immunosorbent assay (ELISA) kits comprised of chemicals and anti-human leptin-receptor, wash buffer, recombinant human leptin-receptor, assay diluent, biotinylated anti-human leptin-receptor, concentrated horseradish peroxidase (HRP)-conjugated streptavidin, tetramethylbenzidine (TMB), and sulfuric acid substances for research purposes, and human endogenous secreted receptor for advanced glycation end products (esRAGE); ELISA kit comprised of chemicals in the nature of sulfuric acid, plate with absorbed anti-RAGE antibody, esRAGE intibody-horseradish peroxidase conjugated as Detection Antibody, 3,3', 5, 5'-tetramethylbenzidine and hydrogen peroxide, phosphate buffered saline containing bovine serum albumin, human esRAGE, phosphate buffered saline with Tween 20, for research purposes; interfering ribonucleic acid (RNAi) products, namely, small interfering RNA (siRNA) reagents for scientific research purpose, and GeneNet siRNA libraries and sequences in the nature of polymers for screening genome-wide for genes regulating cellular responses or signaling pathways, identifying potential drug targets or diagnostic markers that inhibit, enhance, or activate a selectable phenotype and finding crucial regulatory genes using routine growth selections or flow sorting; cell culture products, namely, chemicals in the nature of visceral adipocytes, epididymal adipocytes, subcutaneous adipocytes, and osteoclasts; chemicals for use in scientific research preparations, namely, full open reading frame (ORF) clones, full-length clones, sequence verified clones, and genomic clones for applications in protein expression, functional genomics, and functional analysis


First Use Date in General

02th Nov 2000

First Use Date in Commerce

03rd Jan 2002

Class [042]
Computer & Software Services & Scientific Services


Biological research, consulting, and analytical services, provided by scientists, in the nature of analysis of chemicals and biological sequences, sample analysis, ribonucleic acid (RNA) design in the nature of polymer design, small interfering ribonucleic acid (siRNA) design, siRNA synthesis in the nature of synthesis of polymers for scientific research, biological research of cells, cell strain, biochemical mechanisms, antibodies and proteins, apoptosis detection, cell culture, clones, food, and nucleic acid purification; providing of chemical laboratory facilities


First Use Date in General

02th Nov 2000

First Use Date in Commerce

03rd Jan 2002

Mark Details


Serial Number

No 76664863

Mark Type

No Service Mark

Attorney Docket Number

No B-BRIDGE-01T

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th Mar 2015CANCELLED SEC. 8 (6-YR)
19th Aug 2008REGISTERED-PRINCIPAL REGISTER
03rd Jun 2008PUBLISHED FOR OPPOSITION
14th May 2008NOTICE OF PUBLICATION
30th Apr 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
30th Apr 2008EXAMINERS AMENDMENT -WRITTEN
30th Apr 2008APPROVED FOR PUB - PRINCIPAL REGISTER
30th Apr 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
30th Apr 2008EXAMINER'S AMENDMENT ENTERED
30th Apr 2008EXAMINERS AMENDMENT E-MAILED